Torsdag 13 Mars | 21:02:38 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2026-02-04 07:50 Bokslutskommuniké 2025
2025-10-23 07:50 Kvartalsrapport 2025-Q3
2025-07-15 07:50 Kvartalsrapport 2025-Q2
2025-05-09 N/A X-dag ordinarie utdelning ALIF B 0.75 SEK
2025-05-08 N/A Årsstämma
2025-04-25 07:50 Kvartalsrapport 2025-Q1
2025-02-05 - Bokslutskommuniké 2024
2024-10-23 - Kvartalsrapport 2024-Q3
2024-07-15 - Kvartalsrapport 2024-Q2
2024-05-10 - X-dag ordinarie utdelning ALIF B 0.50 SEK
2024-05-08 - Årsstämma
2024-04-24 - Kvartalsrapport 2024-Q1
2024-02-02 - Bokslutskommuniké 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-07-14 - Kvartalsrapport 2023-Q2
2023-05-05 - X-dag ordinarie utdelning ALIF B 1.20 SEK
2023-05-04 - Årsstämma
2023-04-26 - Kvartalsrapport 2023-Q1
2023-02-02 - Bokslutskommuniké 2022
2022-10-27 - Kvartalsrapport 2022-Q3
2022-07-15 - Kvartalsrapport 2022-Q2
2022-05-06 - X-dag ordinarie utdelning ALIF B 2.00 SEK
2022-05-05 - Årsstämma
2022-04-28 - Kvartalsrapport 2022-Q1
2022-02-04 - Bokslutskommuniké 2021
2021-10-22 - Kvartalsrapport 2021-Q3
2021-07-15 - Kvartalsrapport 2021-Q2
2021-05-06 - X-dag ordinarie utdelning ALIF B 1.50 SEK
2021-05-05 - Årsstämma
2021-04-28 - Kvartalsrapport 2021-Q1
2021-02-03 - Bokslutskommuniké 2020
2020-11-20 - X-dag ordinarie utdelning ALIF B 0.50 SEK
2020-11-20 - X-dag bonusutdelning ALIF B 0.5
2020-11-19 - Extra Bolagsstämma 2020
2020-10-22 - Kvartalsrapport 2020-Q3
2020-07-17 - Kvartalsrapport 2020-Q2
2020-05-27 - Split ALIF B 1:4
2020-05-08 - X-dag ordinarie utdelning ALIF B 2.40 SEK
2020-05-07 - Årsstämma
2020-04-28 - Kvartalsrapport 2020-Q1
2020-02-06 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-07-12 - Kvartalsrapport 2019-Q2
2019-05-10 - X-dag ordinarie utdelning ALIF B 2.20 SEK
2019-05-09 - Årsstämma
2019-05-09 - Kvartalsrapport 2019-Q1
2019-02-12 - Bokslutskommuniké 2018
2018-12-20 - Extra Bolagsstämma 2018
2018-11-07 - Kvartalsrapport 2018-Q3
2018-07-13 - Kvartalsrapport 2018-Q2
2018-06-01 - X-dag ordinarie utdelning ALIF B 2.20 SEK
2018-05-31 - Årsstämma
2018-04-27 - Kvartalsrapport 2018-Q1
2018-02-13 - Bokslutskommuniké 2017
2017-10-26 - Kvartalsrapport 2017-Q3
2017-07-17 - Kvartalsrapport 2017-Q2
2017-05-30 - X-dag ordinarie utdelning ALIF B 1.50 SEK
2017-05-29 - Årsstämma
2017-04-28 - Kvartalsrapport 2017-Q1
2017-02-16 - Bokslutskommuniké 2016
2016-10-27 - Kvartalsrapport 2016-Q3
2016-09-02 - X-dag ordinarie utdelning ALIF B 0.00 SEK
2016-09-01 - Årsstämma
2016-07-15 - Kvartalsrapport 2016-Q2

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
AddLife är verksamt inom medicinteknikbranschen och fokuserar på utveckling, tillverkning och distribution av medicinsk utrustning och laboratorieprodukter. Bolagets produkter riktar sig till sjukvårdsinstitutioner och forskningslaboratorier. Verksamheten är global med en huvudsaklig närvaro i Europa, Nordamerika och Asien. AddLife grundades 2016 och har sitt huvudkontor i Stockholm, Sverige.
2025-02-05 07:45:00

AddLife finishes the year with high growth, improved margins, and strong cash flow

"AddLife finishes 2024 with a very strong fourth quarter. Organic growth was 9%, EBITA increased by 24%, and cash flow improved by 49%. The companies within AddLife performed very well, driven by positive demand development and dedicated, long-term efficiency efforts."
Fredrik Dalborg, President and CEO

AddLife's year-end report for Q4 2024 is now available online at the company website. The year-end report can be downloaded in pdf version. Visit reports-en.add.life/year-end-report-q4-2024

1 OCTOBER- 31 DECEMBER 2024 (3 MONTHS)

  • Net sales increased by 11% to SEK 2,818m (2,544). The organic growth, excluding exchange rate changes, was 9% and the acquired growth was 1%.
  • EBITA increased by 24% to SEK 346m (278), corresponding to an EBITA-margin of 12.3% (10.9). The EBITA margin for the previous year was 10.2%, adjusted for reversed contingent considerations and one-off costs.
  • Profit after tax amounted to SEK 94m (-41).
  • Earnings per share amounted to SEK 0.76 (-0.34).
  • Cash flow from operating activities amounted to SEK 666m (448).

1 JANUARY - 31 DECEMBER 2024 (12 MONTHS)

  • Net sales increased by 6% to SEK 10,286m (9,685). The organic growth, excluding exchange rate changes, was 5%.
  • EBITA increased by 2% to SEK 1,159m (1,135), corresponding to an EBITA-margin of 11.3% (11.7). Adjusted for revalued contingent considerations and restructuring costs, EBITA amounted to SEK 1,165m (1,015). Excluding these, EBITA increased by 14% and the EBITA-margin amounted to 11.3% (10.5).
  • Profit after tax amounted to SEK 254m (192).
  • Earnings per share amounted to SEK 2.06 (1.56).
  • Cash flow from operating activities amounted to SEK 1,095m (773).
  • The equity ratio was 41% (39).
  • Return on working capital (P/WC) amounted to 51% (50).
  • During the financial year an acquisition, BonsaiLab SLU, was completed. The acquisition is estimated to contribute with an annual net sale of approximately SEK 90m.
  • The board proposes a dividend of SEK 0.75 per share.


Stockholm, February 5, 2025
AddLife AB (publ)

For more information, contact;
Fredrik Dalborg, CEO, fredrik.dalborg@add.life, +46 70 516 09 01
Christina Rubenhag, CFO, christina.rubenhag@add.life, +46 70 546 72 22
www.add.life

Video conference
Investors, analysts and the media are invited to a video conference at which CEO Fredrik Dalborg and CFO Christina Rubenhag will present the
year-end report . The presentation will be given in English and take about 20 minutes. after which there will be an opportunity to ask questions. The meeting will be recorded and made available online.

The video conference will be at 9 a.m. CET on February 5, 2025.

If you wish to participate via video conference, please follow this link>>

The presentation is also available on AddLife YouTube >>

AddLife is an independent player in the Life Science industry that offers high-quality products, services and advice to both the private and public sectors, mainly in the Nordic region and rest of Europe. AddLife has about 2,300 employees in some 85 operating subsidiaries. The Group currently has net sales of more than SEK 10 billion. AddLife shares are listed on Nasdaq Stockholm.

This information is information that AddLife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at February 5, 2025 at 07:45 a.m. CET.